Works by Maruyama, Shoichi


Results: 265
    1
    2
    3

    Safety and efficacy of retreatment with immune checkpoint inhibitors after severe immune-related adverse events.

    Published in:
    Oncologist, 2025, v. 30, n. 6, p. 1, doi. 10.1093/oncolo/oyaf120
    By:
    • Mizuno, Kazuyuki;
    • Ito, Takanori;
    • Sawada, Tsunaki;
    • Kobayashi, Tomoko;
    • Iwama, Shintaro;
    • Mori, Shoichiro;
    • Hase, Tetsunari;
    • Fukami, Yuki;
    • Furusawa, Kenji;
    • Yura, Yoshimitsu;
    • Morimoto, Ryota;
    • Sajiki, Ai Fujita;
    • Ushida, Hiroaki;
    • Kato, Noritoshi;
    • Maruyama, Shoichi;
    • Murohara, Toyoaki;
    • Katsuno, Masahisa;
    • Ishii, Makoto;
    • Akiyama, Masashi;
    • Arima, Hiroshi
    Publication type:
    Article
    4
    5
    6
    7

    Factors affecting the sodium‐glucose cotransporter 2 inhibitors‐related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database

    Published in:
    Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2905, doi. 10.1111/dom.15611
    By:
    • Kanaoka, Tomohiko;
    • Wakui, Hiromichi;
    • Yano, Yuichiro;
    • Nagasu, Hajime;
    • Kanegae, Hiroshi;
    • Nangaku, Masaomi;
    • Hirakawa, Yosuke;
    • Nakagawa, Naoki;
    • Wada, Jun;
    • Tsuruya, Kazuhiko;
    • Nakano, Toshiaki;
    • Maruyama, Shoichi;
    • Wada, Takashi;
    • Konishi, Masaaki;
    • Nagahiro, Takanori;
    • Yamagata, Kunihiro;
    • Narita, Ichiei;
    • Yanagita, Motoko;
    • Terada, Yoshio;
    • Araki, Shinichi
    Publication type:
    Article
    8

    Hyporesponsiveness to erythropoiesis-stimulating agent in non-dialysis-dependent CKD patients: The BRIGHTEN study.

    Published in:
    PLoS ONE, 2022, v. 17, n. 11, p. 1, doi. 10.1371/journal.pone.0277921
    By:
    • Narita, Ichiei;
    • Hayashi, Terumasa;
    • Maruyama, Shoichi;
    • Masaki, Takao;
    • Nangaku, Masaomi;
    • Nishino, Tomoya;
    • Sato, Hiroshi;
    • Sofue, Tadashi;
    • Wada, Takashi;
    • Imai, Enyu;
    • Iwasaki, Manabu;
    • Mizuno, Kyoichi;
    • Hase, Hiroki;
    • Kamouchi, Masahiro;
    • Yamamoto, Hiroyasu;
    • Kagimura, Tatsuo;
    • Tanabe, Kenichiro;
    • Kato, Hideki;
    • Wada, Takehiko;
    • Usui, Tomoko
    Publication type:
    Article
    9
    10

    Real-world safety profile of eculizumab in patients with paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome, or generalized myasthenia gravis: an integrated analysis of post-marketing surveillance in Japan.

    Published in:
    International Journal of Hematology, 2023, v. 118, n. 4, p. 419, doi. 10.1007/s12185-023-03630-x
    By:
    • Nishimura, Jun-ichi;
    • Kawaguchi, Tatsuya;
    • Ito, Shuichi;
    • Murai, Hiroyuki;
    • Shimono, Akihiko;
    • Matsuda, Takahisa;
    • Fukamizu, Yuji;
    • Akiyama, Hirozumi;
    • Hayashi, Hideo;
    • Nakano, Takashi;
    • Maruyama, Shoichi
    Publication type:
    Article
    11
    12

    Relationship between the lower limit of systolic blood pressure target and kidney function decline in advanced chronic kidney disease: an instrumental variable analysis from the REACH-J CKD cohort study.

    Published in:
    Hypertension Research, 2023, v. 46, n. 11, p. 2478, doi. 10.1038/s41440-023-01358-z
    By:
    • Kurasawa, Shimon;
    • Yasuda, Yoshinari;
    • Kato, Sawako;
    • Maruyama, Shoichi;
    • Okada, Hirokazu;
    • Kashihara, Naoki;
    • Narita, Ichiei;
    • Wada, Takashi;
    • Yamagata, Kunihiro;
    • Hirayama, Tomoya;
    • Togashi, Nobuhiko;
    • Sugiura, Akira;
    • Shiigai, Tatsuo;
    • Ueki, Kazue;
    • Kikkawa, Ken;
    • Nakamura, Tsukasa;
    • Sato, Eiichi;
    • Matsukuma, Hideki;
    • Harasawa, Shinsuke;
    • Washio, Takehiko
    Publication type:
    Article
    13

    Cardiovascular disease history and β-blocker prescription patterns among Japanese and American patients with CKD: a cross-sectional study of the CRIC and CKD-JAC studies.

    Published in:
    Hypertension Research, 2021, v. 44, n. 6, p. 700, doi. 10.1038/s41440-020-00608-8
    By:
    • Imaizumi, Takahiro;
    • Hamano, Takayuki;
    • Fujii, Naohiko;
    • Huang, Jing;
    • Xie, Dawei;
    • Ricardo, Ana C.;
    • He, Jiang;
    • Soliman, Elsayed Z.;
    • Kusek, John W.;
    • Nessel, Lisa;
    • Yang, Wei;
    • Maruyama, Shoichi;
    • Fukagawa, Masafumi;
    • Feldman, Harold I.;
    • the CRIC Study Investigators;
    • Appel, Lawrence J.;
    • Go, Alan S.;
    • Lash, James P.;
    • Nelson, Robert G.;
    • Rahman, Mahboob
    Publication type:
    Article
    14
    15
    16
    17
    18

    Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study.

    Published in:
    Nephrology Dialysis Transplantation, 2023, v. 38, n. 1, p. 158, doi. 10.1093/ndt/gfac041
    By:
    • Imasawa, Toshiyuki;
    • Saito, Chie;
    • Kai, Hirayasu;
    • Iseki, Kunitoshi;
    • Kazama, Junichiro James;
    • Shibagaki, Yugo;
    • Sugiyama, Hitoshi;
    • Nagata, Daisuke;
    • Narita, Ichiei;
    • Nishino, Tomoya;
    • Hasegawa, Hajime;
    • Honda, Hirokazu;
    • Maruyama, Shoichi;
    • Miyazaki, Mariko;
    • Mukoyama, Masashi;
    • Yasuda, Hideo;
    • Wada, Takashi;
    • Ishikawa, Yuichi;
    • Tsunoda, Ryoya;
    • Nagai, Kei
    Publication type:
    Article
    19
    20

    Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.

    Published in:
    Nephrology Dialysis Transplantation, 2021, v. 36, n. 8, p. 1452, doi. 10.1093/ndt/gfaa097
    By:
    • Yokoe, Yuki;
    • Tsuboi, Naotake;
    • Imaizumi, Takahiro;
    • Kitagawa, Akimitsu;
    • Karasawa, Munetoshi;
    • Ozeki, Takaya;
    • Endo, Nobuhide;
    • Sawa, Yuriko;
    • Kato, Sawako;
    • Katsuno, Takayuki;
    • Maruyama, Shoichi;
    • Yamagata, Kunihiro;
    • Usui, Joichi;
    • Nagata, Michio;
    • Sada, Ken-Ei;
    • Sugiyama, Hitoshi;
    • Amano, Koichi;
    • Arimura, Yoshihiro;
    • Atsumi, Tatsuya;
    • Yuzawa, Yukio
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Introduction.

    Published in:
    2023
    By:
    • Kanetsuna, Yukiko;
    • Maruyama, Shoichi
    Publication type:
    Editorial
    33

    Association between proteinuria and mineral metabolism disorders in chronic kidney disease: the Japan chronic kidney disease database extension (J-CKD-DB-Ex).

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-79291-5
    By:
    • Shimamoto, Sho;
    • Nakahara, Takako;
    • Yamada, Shunsuke;
    • Nagasu, Hajime;
    • Kishi, Seiji;
    • Nakashima, Naoki;
    • Tsuruya, Kazuhiko;
    • Okada, Hirokazu;
    • Tamura, Kouichi;
    • Narita, Ichiei;
    • Maruyama, Shoichi;
    • Yano, Yuichiro;
    • Yokoo, Takashi;
    • Wada, Takashi;
    • Wada, Jun;
    • Kanda, Eiichiro;
    • Kataoka, Hiromi;
    • Nangaku, Masaomi;
    • Kashihara, Naoki;
    • Nakano, Toshiaki
    Publication type:
    Article
    34

    Evaluating the associations between compliance with CKD guideline component metrics and renal outcomes.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-62152-6
    By:
    • Nyma, Zannatun;
    • Kitaoka, Kaori;
    • Yano, Yuichiro;
    • Kanegae, Hiroshi;
    • Bayaraa, Nomin;
    • Kishi, Seiji;
    • Nagasu, Hajime;
    • Nakano, Toshiaki;
    • Wada, Jun;
    • Maruyama, Shoichi;
    • Nakagawa, Naoki;
    • Tamura, Kouichi;
    • Yokoo, Takashi;
    • Yanagita, Motoko;
    • Narita, Ichiei;
    • Yamagata, Kunihiro;
    • Wada, Takashi;
    • Tsuruya, Kazuhiko;
    • Nakashima, Naoki;
    • Isaka, Yoshitaka
    Publication type:
    Article
    35
    36

    Pathological Observations in HTLV-I Associated Myelopathy.

    Published in:
    Psychiatry & Clinical Neurosciences, 1989, v. 43, n. 4, p. 703, doi. 10.1111/j.1440-1819.1989.tb03105.x
    By:
    • Kobayashi, Itsuro;
    • Ota, Kohei;
    • Yamamoto, Kenji;
    • Murakami, Hirohiko;
    • Maruyama, Shoichi;
    • Kasajima, Takeshi;
    • Masuda, Akihiro
    Publication type:
    Article
    37
    38

    Noonan's Syndrome with Syringomyelia.

    Published in:
    Psychiatry & Clinical Neurosciences, 1986, v. 40, n. 1, p. 101, doi. 10.1111/j.1440-1819.1986.tb01616.x
    By:
    • Kobayashi, Itsuro;
    • Aikawa, Takashi;
    • Takemiya, Toshiko;
    • Maruyama, Shoichi;
    • Takano, Kazue
    Publication type:
    Article
    39

    L-Dopa-Induced Asterixis.

    Published in:
    Psychiatry & Clinical Neurosciences, 1985, v. 39, n. 4, p. 507, doi. 10.1111/j.1440-1819.1985.tb00804.x
    By:
    • Kobayashi, Itsuro;
    • Osawa, Mikio;
    • Ohta, Kohei;
    • Maruyama, Shoichi
    Publication type:
    Article
    40

    Prevalences of hyperuricemia and electrolyte abnormalities in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).

    Published in:
    PLoS ONE, 2020, v. 15, n. 10, p. 1, doi. 10.1371/journal.pone.0240402
    By:
    • Sofue, Tadashi;
    • Nakagawa, Naoki;
    • Kanda, Eiichiro;
    • Nagasu, Hajime;
    • Matsushita, Kunihiro;
    • Nangaku, Masaomi;
    • Maruyama, Shoichi;
    • Wada, Takashi;
    • Terada, Yoshio;
    • Yamagata, Kunihiro;
    • Narita, Ichiei;
    • Yanagita, Motoko;
    • Sugiyama, Hitoshi;
    • Shigematsu, Takashi;
    • Ito, Takafumi;
    • Tamura, Kouichi;
    • Isaka, Yoshitaka;
    • Okada, Hirokazu;
    • Tsuruya, Kazuhiko;
    • Yokoyama, Hitoshi
    Publication type:
    Article
    41

    Prevalence of anemia in patients with chronic kidney disease in Japan: A nationwide, cross-sectional cohort study using data from the Japan Chronic Kidney Disease Database (J-CKD-DB).

    Published in:
    PLoS ONE, 2020, v. 15, n. 7, p. 1, doi. 10.1371/journal.pone.0236132
    By:
    • Sofue, Tadashi;
    • Nakagawa, Naoki;
    • Kanda, Eiichiro;
    • Nagasu, Hajime;
    • Matsushita, Kunihiro;
    • Nangaku, Masaomi;
    • Maruyama, Shoichi;
    • Wada, Takashi;
    • Terada, Yoshio;
    • Yamagata, Kunihiro;
    • Narita, Ichiei;
    • Yanagita, Motoko;
    • Sugiyama, Hitoshi;
    • Shigematsu, Takashi;
    • Ito, Takafumi;
    • Tamura, Kouichi;
    • Isaka, Yoshitaka;
    • Okada, Hirokazu;
    • Tsuruya, Kazuhiko;
    • Yokoyama, Hitoshi
    Publication type:
    Article
    42
    43
    44
    45

    Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database.

    Published in:
    2021
    By:
    • Nagasu, Hajime;
    • Yano, Yuichiro;
    • Kanegae, Hiroshi;
    • Heerspink, Hiddo J.L.;
    • Nangaku, Masaomi;
    • Hirakawa, Yosuke;
    • Sugawara, Yuka;
    • Nakagawa, Naoki;
    • Tani, Yuji;
    • Wada, Jun;
    • Sugiyama, Hitoshi;
    • Tsuruya, Kazuhiko;
    • Nakano, Toshiaki;
    • Maruyama, Shoichi;
    • Wada, Takashi;
    • Yamagata, Kunihiro;
    • Narita, Ichiei;
    • Tamura, Kouichi;
    • Yanagita, Motoko;
    • Terada, Yoshio
    Publication type:
    journal article
    46
    47
    48

    CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease.

    Published in:
    2018
    By:
    • Kayaho Maeda;
    • Kotaro Otomo;
    • Nobuya Yoshida;
    • Abu-Asab, Mones S.;
    • Kunihiro Ichinose;
    • Tomoya Nishino;
    • Michihito Kono;
    • Ferretti, Andrew;
    • Bhargava, Rhea;
    • Shoichi Maruyama;
    • Bickerton, Sean;
    • Fahmy, Tarek M.;
    • Tsokos, Maria G.;
    • Tsokos, George C.;
    • Maeda, Kayaho;
    • Otomo, Kotaro;
    • Yoshida, Nobuya;
    • Ichinose, Kunihiro;
    • Nishino, Tomoya;
    • Kono, Michihito
    Publication type:
    journal article
    49
    50